Concord Biotech Ltd
NSE:CONCORDBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Concord Biotech Ltd
NSE:CONCORDBIO
|
IN |
|
R
|
Ryohin Keikaku Co Ltd
OTC:RYKKF
|
JP |
|
Capital Southwest Corp
NASDAQ:CSWC
|
US |
|
C
|
Charles Schwab Corp
XBER:SWG
|
US |
|
Metcash Ltd
ASX:MTS
|
AU |
|
Wal Mart de Mexico SAB de CV
BMV:WALMEX
|
MX |
|
D
|
Deutsche Telekom AG
OTC:DTEGF
|
DE |
|
EssilorLuxottica SA
PAR:EL
|
FR |
|
Titan International Inc
NYSE:TWI
|
US |
|
Kimberly-Clark Corp
NYSE:KMB
|
US |
|
T
|
Tharisa PLC
JSE:THA
|
CY |
|
Comfort Systems USA Inc
NYSE:FIX
|
US |
|
International Business Machines Corp
NYSE:IBM
|
US |
|
J
|
J B Hunt Transport Services Inc
DUS:JB1
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
M
|
Mr Price Group Ltd
JSE:MRP
|
ZA |
|
W
|
Westrock Co
LSE:0LW9
|
US |
Wall St Price Targets
CONCORDBIO Price Targets Summary
Concord Biotech Ltd
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 181.5 INR with a low forecast of 1 030.2 INR and a high forecast of 1 338.75 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CONCORDBIO's stock price target?
Price Target
1 181.5
INR
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 181.5 INR with a low forecast of 1 030.2 INR and a high forecast of 1 338.75 INR.
What is the Revenue forecast for Concord Biotech Ltd?
Projected CAGR
14%
Over the last 4 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 14%.
What is the Gross Profit forecast for Concord Biotech Ltd?
Projected CAGR
19%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 3 years is 19%.
What is the Operating Income forecast for Concord Biotech Ltd?
Projected CAGR
14%
Over the last 4 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 14%.
What is the Pre-Tax Income forecast for Concord Biotech Ltd?
Projected CAGR
13%
Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 13%.
What is the Net Income forecast for Concord Biotech Ltd?
Projected CAGR
13%
Over the last 4 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 13%.
